Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,052 | -3,845 | -25,954 | -18,617 | -14,759 |
| Depreciation Amortization | 731 | 671 | 2,612 | 1,949 | 1,288 |
| Accounts receivable | -508 | -361 | -1,454 | -1,417 | 254 |
| Accounts payable and accrued liabilities | -915 | -817 | -80 | -98 | -209 |
| Other Working Capital | -1,771 | -1,923 | -400 | -990 | 534 |
| Other Operating Activity | 1,950 | 2,165 | 3,699 | 3,521 | 1,557 |
| Operating Cash Flow | $-9,565 | $-4,110 | $-21,577 | $-15,652 | $-11,335 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,024 | -4,231 | -3,779 | -3,279 | -7,139 |
| PPE Investments | -156 | -131 | -759 | -673 | -457 |
| Other Investing Activity | -2,020 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,152 | $-4,362 | $-4,538 | $-3,952 | $-7,596 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 86 | 3 | 8,449 | 8,404 | 336 |
| Other Financing Activity | -604 | -370 | 9,703 | 9,895 | 10,164 |
| Financing Cash Flow | $-518 | $-367 | $18,152 | $18,299 | $10,500 |
| Exchange Rate Effect | -53 | -18 | -245 | -344 | -316 |
| Beginning Cash Position | 20,772 | 20,772 | 28,980 | 28,980 | 28,980 |
| End Cash Position | 9,484 | 11,915 | 20,772 | 27,331 | 20,233 |
| Net Cash Flow | $-11,288 | $-8,857 | $-8,208 | $-1,649 | $-8,747 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,565 | -4,110 | -21,577 | -15,652 | -11,335 |
| Capital Expenditure | -166 | -141 | -785 | -699 | -483 |
| Free Cash Flow | -9,731 | -4,251 | -22,362 | -16,351 | -11,818 |